Skip to the main content
The Crier

Manufacturing, Packaging, Labelling and Distribution of the Investigational Medicinal Product (Imp) for the Option-DM Trial (Optimal Pathway for Treating Neuropathic Pain in Diabetes Mellitus Trial)

Your saved contracts

What the buyer wrote

Text to be corrected in the original notice: Place of text to be modified: Time limit for receipt of tenders Instead of: Read: Other additional information: The contracting authority considers that this contract may be suitable for economic operators that are small or medium enterprises (SMEs). However, any selection of tenderers will be based solely on the criteria set out for the procurement. INVITATION TO TENDER FOR THE: PROVISION OF MANUFACTURING, PACKAGING, LABELLING AND DISTRIBUTION OF THE INVESTIGATIONAL MEDICINAL PRODUCT (IMP) FOR THE OPTION-DM TRIAL (OPTIMAL PATHWAY FOR TREATING NEUROPATHIC PAIN IN DIABETES MELLITUS TRIAL)

Details

What the buyer calls it
Manufacturing, Packaging, Labelling and Distribution of the Investigational Medicinal Product (Imp) for the Option-DM Trial (Optimal Pathway for Treating Neuropathic Pain in Diabetes Mellitus Trial)
How they are buying
Advertised, open to anyoneAny supplier could bid without being invited first.
Type
goods
Suitable for small firms
The buyer says yes. What that is worth
Work starts
21 Oct 2016
Work ends
21 Apr 2019

Who the buyer named

The buyer published a contact address on this notice.

kay.elliott@sth.nhs.uk